BREAST CANCER|https://phgkb.cdc.gov/GAPPKB/phgHome.do|BREAST CANCER

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: Apr 20, 2017

---

• When to Tell Daughters About a Genetic Breast Cancer Risk  
  JW Harris, NY Times, April 20, 2017
• A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.  
  Eccleston Anthony et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Apr 20(4) 567-576
• A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.  
  Li Yonghong et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Apr 20(4) 547-555
• Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).  
  Pestalozzi Bernhard C et al. BMC cancer 2017 Apr 17(1) 265
• An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.  
  Felts Jesse L et al. The breast journal 2017 Jan
• An exploration of Australian psychologists' role in assessing women considering risk-reducing or contralateral prophylactic mastectomy.  
  Braude Lucy et al. Breast (Edinburgh, Scotland) 2017 Apr 32105-111
• Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.  
  Couch Fergus J et al. JAMA oncology 2017 Apr
• Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.  
  Carmichael Harris et al. Breast cancer research and treatment 2017 Apr 162(2) 225-230
• Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients.  
  Park Boyoung et al. Breast cancer research and treatment 2017 May 163(1) 139-150
• Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.  
  Kurian Allison W et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Apr JCO2016716480
• Genetic Testing in Patients With Newly Diagnosed Breast Cancer: Room for Improvement.  
  Ahn Soojin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Apr JCO2017728816
• Impact of Oncotype DX breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK.  
  Loncaster J et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2017 May 43(5) 931-937
• Multigene Panel Testing and Breast Cancer Risk: Is It Time to Scale Down?  
  Obeid Elias I et al. JAMA oncology 2017 Apr
• Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer.  
  Halpern Naama et al. International journal of cancer 2017 May 140(9) 2145-2149
• Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress. 
  van Erkelens A et al. European journal of cancer (Oxford, England : 1990) 2017 Apr 7845-52
• Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history.  
  Skandarajah Anita R et al. Breast (Edinburgh, Scotland) 2017 Apr 3293-97

more